KPRX
Kiora Pharmaceuticals Inc
NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY
$2.44
+3.83% today
Updated 2026-05-01
Market cap
$10.53M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$2 – $4
Volume
0.6M
Kiora Pharmaceuticals Inc (KPRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.22M | $-2.96M | $-950617.00 | $-4.46M | $-8.41M | $-6.47M | $-10.84M | $-8.15M | $-7.32M | $-10.68M | $-10.43M | $-9.56M | $8.56M | $-9.96M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $11000.00 | $36999.00 | $270000.00 | $20077.00 | $20077.00 | $63865.00 | $0.00 | $1.00 | $6256.00 | $110789.00 |
| Depreciation | $9094.00 | $5455.00 | $1724.00 | $1257.00 | $5185.00 | $19288.00 | $38483.00 | $213933.00 | $33399.00 | $45296.00 | $41609.00 | $51798.00 | $19205.00 | — |
| Stock-based comp | $396375.00 | $184030.00 | $26815.00 | $1.22M | $510995.00 | $870308.00 | $875287.00 | $852230.00 | $723856.00 | $842475.00 | $462450.00 | $754944.00 | $656593.00 | $900236.00 |
| Free cash flow | $-5.22M | $-2.96M | $-950617.00 | $-4.46M | $-8.42M | $-6.51M | $-11.11M | $-8.17M | $-7.34M | $-10.74M | $-10.43M | $-9.56M | $8.55M | $-10.07M |
| Investing cash flow | — | — | — | $-20000.00 | $149746.00 | $-36999.00 | $-270000.00 | $-244438.00 | $-244438.00 | $-157020.00 | $6375.00 | — | $-22.66M | — |
| Financing cash flow | $-75406.00 | $1.46M | $613273.00 | $12.62M | $3.50M | $10.67M | $11.30M | $3.92M | $5.00M | $17.58M | $8.62M | $5.97M | $15.50M | — |
| Dividends paid | — | — | — | — | — | — | — | $7329.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |